Allosteric modulation of muscarinic receptors in alcohol and substance use disorders.

Addiction Alcohol Alcohol use disorder Allosteric modulation Cocaine Extinction Muscarinic receptors Opioid Reinstatement Relapse Self-administration Substance use disorder

Journal

Advances in pharmacology (San Diego, Calif.)
ISSN: 1557-8925
Titre abrégé: Adv Pharmacol
Pays: United States
ID NLM: 9015397

Informations de publication

Date de publication:
2020
Historique:
entrez: 18 5 2020
pubmed: 18 5 2020
medline: 30 9 2020
Statut: ppublish

Résumé

Alcohol and substance use disorders are chronic relapsing disorders, characterized by a compulsion to take drugs and loss of control in limiting intake. The impact of alcohol and substance abuse on morbidity and mortality is very high worldwide, and treatment options are inadequate at a population level. There is a need for the discovery and development of novel pharmacotherapies to treat alcohol and substance use disorders. The recent development of subtype selective muscarinic acetylcholine receptor (mAChR) allosteric modulators, is rapidly increasing our understanding of this system and revealing great promise for disease treatment. In this chapter, we will present and integrate the current literature regarding the role of mAChRs in drug and alcohol abuse with emerging evidence using novel allosteric modulators targeting specific mAChR subtypes. We will focus on the potential of M

Identifiants

pubmed: 32416869
pii: S1054-3589(20)30003-X
doi: 10.1016/bs.apha.2020.01.003
pii:
doi:

Substances chimiques

Receptors, Muscarinic 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-275

Informations de copyright

© 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest statement The authors have no conflicts of interest to declare.

Auteurs

Leigh C Walker (LC)

Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.

Andrew J Lawrence (AJ)

Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia. Electronic address: andrew.lawrence@florey.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH